---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-001476"
form_type: "8-K"
ticker: "DRMA"
cik: "0001853816"
company_name: "Dermata Therapeutics, Inc."
filed_at: "2023-02-08T23:59:59+00:00"
generated_at: "2026-06-19T22:01:51.010633+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Dermata shareholders approve reverse stock split with ratio up to 1:40

## Summary
- Reverse stock split proposal approved: 7,622,928 for, 135,481 against.
- Board authorized to set ratio between 1:2 and 1:40, exact ratio to be determined later.
- Adjournment proposal also approved with 7,681,932 votes for.
- Special meeting held Feb 8, 2023; vote based on 12,321,848 shares outstanding.

## SEC filing metadata
- accession: 0001654954-23-001476
- form_type: 8-K
- ticker: DRMA
- cik: 0001853816
- company_name: Dermata Therapeutics, Inc.
- filed_at: 2023-02-08T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1853816/000165495423001476/0001654954-23-001476-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1853816/000165495423001476/drma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-001476
- JSON: https://secwatch.observer/filing/0001654954-23-001476.json
- Plain text: https://secwatch.observer/filing/0001654954-23-001476.txt

## Key facts
- Shareholder Votes
  Dermata Therapeutics, Inc. shareholders approved Approval of the adjournment of the special meeting to the extent there are insufficient votes to approve the reverse stock split proposal at the 2023-02-08 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2023-02-08
  source text: Proposal No. 2 : The Adjournment Proposal was approved by a vote of stockholders as follows: Votes For Votes Against Abstentions 7,681,932 87,554 28,592
  evidence_url: https://www.sec.gov/Archives/edgar/data/1853816/000165495423001476/0001654954-23-001476-index.htm
- Shareholder Votes
  Dermata Therapeutics, Inc. shareholders approved Adoption and approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split at a ratio from one-for-two to one-for-forty, with the exact ratio determined by the board at the 2023-02-08 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2023-02-08
  source text: Proposal No. 1 : The Reverse Stock Split Proposal was approved by a vote of stockholders as follows: Votes For Votes Against Abstentions 7,622,928 135,481 39,669
  evidence_url: https://www.sec.gov/Archives/edgar/data/1853816/000165495423001476/0001654954-23-001476-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.